{"id":131244,"date":"2026-09-16T02:57:29","date_gmt":"2026-09-16T02:57:29","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/131244\/"},"modified":"2026-09-16T02:57:29","modified_gmt":"2026-09-16T02:57:29","slug":"nestle-develops-products-aimed-at-millions-using-glp-1-drugs","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/131244\/","title":{"rendered":"Nestl\u00e9 develops products aimed at millions using GLP-1 drugs"},"content":{"rendered":"<p>Summary:<\/p>\n<p>\u2013 Nestl\u00e9 is turning weight-loss drugs into a new <a href=\"https:\/\/journalrecord.com\/tag\/food-industry\/\" class=\"st_tag internal_tag \" rel=\"tag nofollow noopener\" title=\"Posts tagged with food industry\" target=\"_blank\">food industry<\/a> opportunity.\n<\/p>\n<p>\u2013 AI is helping the company develop products for GLP-1 users.<\/p>\n<p>\u2013 Experts question whether specialized <a href=\"https:\/\/journalrecord.com\/tag\/nutrition\/\" class=\"st_tag internal_tag \" rel=\"tag nofollow noopener\" title=\"Posts tagged with nutrition\" target=\"_blank\">nutrition<\/a> products are necessary.\n<\/p>\n<p>VEVEY, Switzerland \u2014 <a href=\"https:\/\/journalrecord.com\/tag\/nestle\/\" class=\"st_tag internal_tag \" rel=\"tag nofollow noopener\" title=\"Posts tagged with Nestle\" target=\"_blank\">Nestle<\/a>\u00a0is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a <a href=\"https:\/\/journalrecord.com\/tag\/business\/\" class=\"st_tag internal_tag \" rel=\"tag nofollow noopener\" title=\"Posts tagged with business\" target=\"_blank\">business<\/a> opportunity, using <a href=\"https:\/\/journalrecord.com\/tag\/artificial-intelligence\/\" class=\"st_tag internal_tag \" rel=\"tag nofollow noopener\" title=\"Posts tagged with artificial intelligence\" target=\"_blank\">artificial intelligence<\/a> and nutritional science to develop products aimed at millions of consumers taking medicines such as <a href=\"https:\/\/journalrecord.com\/tag\/ozempic\/\" class=\"st_tag internal_tag \" rel=\"tag nofollow noopener\" title=\"Posts tagged with Ozempic\" target=\"_blank\">Ozempic<\/a> and <a href=\"https:\/\/journalrecord.com\/tag\/wegovy\/\" class=\"st_tag internal_tag \" rel=\"tag nofollow noopener\" title=\"Posts tagged with Wegovy\" target=\"_blank\">Wegovy<\/a>.\n<\/p>\n<p>The rapid adoption of drugs made by <a href=\"https:\/\/journalrecord.com\/tag\/novo-nordisk\/\" class=\"st_tag internal_tag \" rel=\"tag nofollow noopener\" title=\"Posts tagged with Novo Nordisk\" target=\"_blank\">Novo Nordisk<\/a> and <a href=\"https:\/\/journalrecord.com\/tag\/eli-lilly\/\" class=\"st_tag internal_tag \" rel=\"tag nofollow noopener\" title=\"Posts tagged with Eli Lilly\" target=\"_blank\">Eli Lilly<\/a> has fuelled investor concerns that appetite-suppressing medicines could permanently reduce demand for packaged foods, snacks and beverages.<\/p>\n<p>Nestle\u00a0believes the drugs are also creating a new market for products designed to address the side effects of rapid weight loss.\n<\/p>\n<p>Chief Technology Officer Stefan Palzer told Reuters that\u00a0Nestle\u00a0was using AI and other technology to analyse clinical research, identify nutrient combinations and develop products tailored to GLP-1 users.\n<\/p>\n<p>\u201cWe are well positioned with the portfolio. It\u2019s a huge opportunity for our company,\u201d he said.\n<\/p>\n<p>Presentation materials shown to Reuters detailed side effects associated with rapid weight loss, including muscle loss and the loss of facial fat often referred to as \u201cOzempic face\u201d, and outlined areas where\u00a0Nestle\u00a0believes its products can help address them.\n<\/p>\n<p>The GLP-1 market is dominated by Eli Lilly\u2019s Mounjaro and Zepbound and Novo Nordisk\u2019s Wegovy and Ozempic.\n<\/p>\n<p>Around 16 million Americans are taking GLP-1 medicines, according to Boston Consulting Group, a figure expected to rise sharply by the end of the decade.\n<\/p>\n<p>Nestle\u2018s response has been to develop products tailored to the needs of weight-loss drug users while using AI to accelerate research, product development and consumer analysis.\n<\/p>\n<p>Tackling side effects<\/p>\n<p>Palzer said\u00a0Nestle\u2018s scientists have been studying the consequences of rapid weight loss and developing products designed to help consumers manage them.\n<\/p>\n<p>The company is using AI tools to process large volumes of clinical research and identify combinations of nutrients that may help support muscle health, hydration and nutritional intake.\n<\/p>\n<p>Nestle\u00a0has begun adding collagen protein to products under its Vital Proteins brand to address concerns around skin, hair and nail health linked to rapid weight loss.\n<\/p>\n<p>\u201cA big part of weight loss is that people lose lean muscle mass,\u201d Palzer said.\n<\/p>\n<p>\u201cWe found a combination of two micronutrients which we industrialized that stimulate the growth of muscle tissue. On one hand you provide protein, on the other hand you stimulate the muscle tissue to grow back faster.\u201d\n<\/p>\n<p>Palzer said\u00a0Nestle\u00a0had also patented combinations of proprietary ingredients designed to reduce appetite among consumers who often experience increased hunger after discontinuing GLP-1 treatments.\n<\/p>\n<p>The company has already launched products aimed at GLP-1 users.\n<\/p>\n<p>Nestle\u2018s U.S. business created Boost Advanced Nutrition Shake, marketed as containing 35 grams of protein to support muscle health during weight loss. In Asia and Australia,\u00a0Nestle\u00a0has introduced a higher-protein version of its Milo malt drink called Milo PRO High Protein.\n<\/p>\n<p>Rival ice cream makers are also wrestling with the same issues, turning to higher-<a href=\"https:\/\/journalrecord.com\/tag\/protein-products\/\" class=\"st_tag internal_tag \" rel=\"tag nofollow noopener\" title=\"Posts tagged with protein products\" target=\"_blank\">protein products<\/a>, smaller portions and simpler ingredient lists.\n<\/p>\n<p>AI recipe book<\/p>\n<p>AI is playing a growing role throughout that process.\n<\/p>\n<p>Nestle\u00a0has developed internal systems to analyse scientific literature, simulate consumer behaviour, identify emerging trends and help product developers navigate a database of roughly 120,000 recipes.\n<\/p>\n<p>Among those tools is an internal platform called Food Genie, which Palzer said helps scientists and product developers predict how recipes might perform and identify opportunities for reformulation.\n<\/p>\n<p>\u201cYou can imagine if you\u2019re a small company you have only a thousand recipes. It\u2019s very difficult to model and predict recipes using AI,\u201d he said.\n<\/p>\n<p>\u201cAI needs data.\u201d\n<\/p>\n<p>Nestle\u00a0is also testing AI-driven consumer simulations designed to predict how shoppers will respond to new products and health claims before they reach shelves.\n<\/p>\n<p>The company is also using AI to monitor social media and identify emerging consumer trends.\n<\/p>\n<p>\u201cYou see noise around certain topics and then you can conclude whether that\u2019s a lasting trend or not,\u201d Palzer said.\n<\/p>\n<p>\u201cIncreasingly AI will get into this field.\u201d\n<\/p>\n<p>Not everyone is convinced<\/p>\n<p>Some nutrition experts question whether specialised products offer significant advantages over conventional foods.\n<\/p>\n<p>\u201cIt\u2019s quite sad that we turn to new products all the time that are more expensive than whole, fresh food that also contain the same protein and nutrients,\u201d said Amanda Avery, associate professor in nutrition and dietetics at the University of Nottingham in central England.\n<\/p>\n<p>She noted that meat, fish, eggs, dairy products, beans, nuts and pulses remain relatively inexpensive sources of protein and nutrients.\n<\/p>\n<p>Still, Avery said products specifically marketed to GLP-1 users were likely to find buyers.\n<\/p>\n<p>\u201cSadly, we are quite influenced by marketing,\u201d she said. \u201cNestle\u00a0will have done their research.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"Summary: \u2013 Nestl\u00e9 is turning weight-loss drugs into a new food industry opportunity. \u2013 AI is helping the&hellip;\n","protected":false},"author":2,"featured_media":131245,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[126],"tags":[2252,225,336,114,2365,216,15792,47261,4128,1101,161,42747,199,2233,1135,14986,337,56649,597,33750,41266,1904,3615,63750],"class_list":["post-131244","post","type-post","status-publish","format-standard","has-post-thumbnail","category-nestle","tag-ai","tag-artificial-intelligence","tag-biotechnology","tag-business","tag-consumer-products","tag-eli-lilly","tag-food-industry","tag-glp-1-drugs","tag-healthcare","tag-innovation","tag-investing","tag-mounjaro","tag-nestle","tag-novo-nordisk","tag-nutrition","tag-ozempic","tag-pharmaceuticals","tag-protein-products","tag-research-and-development","tag-supplements","tag-wegovy","tag-weight-loss","tag-wellness","tag-zepbound"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/117278477356325370","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/131244","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=131244"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/131244\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/131245"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=131244"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=131244"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=131244"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}